Intellectual Ventures Announces Patent Agreement with Salesforce.com
Intellectual Ventures (IV®) announced today it has entered into an intellectual property agreement with enterprise cloud computing leader salesforce.com.
Intellectual Ventures (IV®) announced today it has entered into an intellectual property agreement with enterprise cloud computing leader salesforce.com.
Intellectual Ventures commissioned market research on intellectual property perceptions and behaviors among C-suite executives in the U.S. to better understand their current views on patents and the growing intellectual property industry.
Intellectual Ventures (IV®) and Check Point Software Technologies Ltd. have reached a settlement agreement that resolves all pending patent infringement litigation between the companies.
Intellectual Ventures (IV) has hired Russ Merbeth as its chief policy counsel. Merbeth will lead Intellectual Ventures’ government relations strategy, coordinate public policy operations, and oversee the Washington, DC office.
Intellectual Ventures (IV®) and Lattice Semiconductor Corporation (NASDAQ: LSCC) announced today that Lattice will become a licensee to segments of IV’s patent portfolio of nearly 40,000 IP assets. As a result of the licensing arrangement, IV and Lattice have reached a settlement agreement and resolved all pending patent infringement litigation.
Intellectual Ventures (IV®) announced today that it has reached a settlement agreement with Microsemi and resolved all pending patent infringement litigation with the company. In addition, Microsemi will become a licensee to segments of IV’s patent portfolio of nearly 40,000 IP assets. “
Intellectual Ventures (IV®) today announced it has entered into an agreement with Adobe Systems Incorporated to provide Adobe with intellectual property services. The agreement includes a membership in IV’s strategic buying program through which Adobe has access to IV’s acquisitions channels to source and buy IP. In addition, Adobe can choose to extend its research and development activities by accessing IV’s invention capabilities.
Intellectual Ventures (IV®) announced today that it has reached a settlement in its patent infringement dispute with Olympus Corporation. In the past two months, four companies including Olympus have resolved patent litigation with Intellectual Ventures. In September, IV moved to dismiss SK hynix Inc. and Elpida Memory, Inc. from patent litigation and, in October, moved to dismiss McAfee, Inc. from different patent litigation.
The Invention Development Fund of Intellectual Ventures (IV), The University of British Columbia (UBC) and BC Cancer Agency have entered into an agreement to further develop and commercialize a new pelvic fracture technology developed by clinicians and engineers at the BC Cancer Agency and Vancouver General Hospital.
Intellectual Ventures (IV®) announced today that it has reached settlement agreements with SK hynix Inc. and Elpida Memory, Inc. and resolved all pending patent infringement litigation with both companies.
Not all good ideas translate to good inventions. View amusing 1930's #invention flops. http://t.co/ml4jZXY9ld
May 24
@aliciakeys @blackberry offer scholarship to bring more women into #STEM #tech and #leadership http://t.co/sWomI9sciB
May 23
"It's pronounced 'jif' not 'gif'." Congrats to GIF #inventor Steve Wilhite @TheWebbyAwards Lifetime Achievement Award http://t.co/9KaoM0RCgD
May 23